Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action

Author： Lorenzati Bartolomeo   Zucco Chiara   Miglietta Sara   Lamberti Federico   Bruno Graziella  

Publisher： MDPI

E-ISSN： 1424-8247|3|9|3005-3020

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.3, Iss.9, 2010-09, pp. : 3005-3020

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond

By Ruck Tobias   Bittner Stefan   Wiendl Heinz   Meuth Sven G.  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 16414-16439

MDPI

Access to resources Recommend Favorite

Mechanism of Action and Applications of Interleukin 24 in Immunotherapy

By Persaud Leah   De Jesus Dayenny   Brannigan Oliver   Richiez-Paredes Maria   Huaman Jeannette   Alvarado Giselle   Riker Linda   Mendez Gissete   Dejoie Jordan   Sauane Moira  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 869-869

MDPI

Access to resources Recommend Favorite

Experimental Basis for the High Oral Toxicity of Dinophysistoxin 1: A Comparative Study of DSP

By Fernández Diego A.   Louzao M. Carmen   Fraga María   Vilariño Natalia   Vieytes Mercedes R.   Botana Luis M.  

Toxins, Vol. 6, Iss. 1, 2014-01 ,pp. : 211-228

MDPI

Access to resources Recommend Favorite

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs

By Klatt Sabine   Fromm Martin F.   König Jörg  

Pharmaceutics, Vol. 3, Iss. 4, 2011-10 ,pp. : 680-705

MDPI

Access to resources Recommend Favorite

miRNA as a New Regulatory Mechanism of Estrogen Vascular Action

By Pérez-Cremades Daniel   Mompeón Ana   Vidal-Gómez Xavier   Hermenegildo Carlos   Novella Susana  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 473-473

MDPI

Access to resources Recommend Favorite